SUMO

抑制剂选择性比较

SUMO产品

目录号 产品描述 文献引用 实验数据
S4922New

NSC 632839

NSC 632839不仅是一种DUB抑制剂,也是一种deSUMOylase抑制剂,作用于USP2, USP7,和SENP2, EC50分别为45 μM, 37 μM和9.8 μM。

S8829New

TAK-981

TAK-981 是一种新型的 SUMOylation enzymatic cascade 的选择性抑制剂,具有潜在的免疫激活和抗肿瘤活性。

S8696

2-D08

2-D08 (2',3',4'-trihydroxy flavone) 是一种具有细胞透性的蛋白类泛素化(protein sumoylation)抑制剂。它还能抑制Axl, IRAK4, ROS1, MLK4, GSK3β, RET (c-RET), KDR和PI3Kα,IC50分别为0.49, 3.9, 5.3, 9.8, 11, 11, 17和35 nM。

S9432

Ginkgolic Acid

Ginkgolic acid, toxic phenolic compounds present in the fruits and leaves of Ginkgo biloba L., is a potent sumoylation inhibitor also reported to inhibit histone acetylation transferase (HAT).

S9445

Ginkgolic Acid (C13:0)

Ginkgolic Acid (C13:0) 是银杏中的一种天然抗龋剂,对变形链球菌(S. mutans)具有抗菌活性,并能抑制与其致龋性相关的特定毒力因子。银杏酸是一种有效的 sumoylation 抑制剂,据报道可抑制 histone acetylation transferase (HAT)

S9159

momordin-Ic

Momordin Ic, a natural triterpenoid saponin, is a novel SENP1 (SUMO-specific protease 1) inhibitor that inhibited proliferation of prostate cancer cells in vitro and in vivo.

目录号 产品描述 文献引用 实验数据
S4922New

NSC 632839

NSC 632839不仅是一种DUB抑制剂,也是一种deSUMOylase抑制剂,作用于USP2, USP7,和SENP2, EC50分别为45 μM, 37 μM和9.8 μM。

S8829New

TAK-981

TAK-981 是一种新型的 SUMOylation enzymatic cascade 的选择性抑制剂,具有潜在的免疫激活和抗肿瘤活性。

S8696

2-D08

2-D08 (2',3',4'-trihydroxy flavone) 是一种具有细胞透性的蛋白类泛素化(protein sumoylation)抑制剂。它还能抑制Axl, IRAK4, ROS1, MLK4, GSK3β, RET (c-RET), KDR和PI3Kα,IC50分别为0.49, 3.9, 5.3, 9.8, 11, 11, 17和35 nM。

S9432

Ginkgolic Acid

Ginkgolic acid, toxic phenolic compounds present in the fruits and leaves of Ginkgo biloba L., is a potent sumoylation inhibitor also reported to inhibit histone acetylation transferase (HAT).

S9445

Ginkgolic Acid (C13:0)

Ginkgolic Acid (C13:0) 是银杏中的一种天然抗龋剂,对变形链球菌(S. mutans)具有抗菌活性,并能抑制与其致龋性相关的特定毒力因子。银杏酸是一种有效的 sumoylation 抑制剂,据报道可抑制 histone acetylation transferase (HAT)

S9159

momordin-Ic

Momordin Ic, a natural triterpenoid saponin, is a novel SENP1 (SUMO-specific protease 1) inhibitor that inhibited proliferation of prostate cancer cells in vitro and in vivo.

Tags: SUMO Inhibition | SUMO antibody | SUMO inhibitors | SUMO modulation